iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in iTeos Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 143
- −10 vs. Q2 2022
- Shares held
- 36.6M
- −490.8K (−1.3%) vs. Q2 2022
- Total value
- $698.2M
- −$69.9M (−9.1%) vs. Q2 2022
- New holders
- 18
- 62 more added
- Sold out
- 28
- 35 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Massachusetts Financial Services Co | 121,240 | $2.31M | 0.00% | −1,106−0.9% | Reduced |
| Wellington Management Group LLP | 122,413 | $2.33M | 0.00% | +17,738+16.9% | Added |
| Rafferty Asset Management, LLC | 126,101 | $2.40M | 0.03% | +26,733+26.9% | Added |
| Prudential Financial Inc | 144,861 | $2.76M | 0.00% | +32,355+28.8% | Added |
| Baker Bros. Advisors LP | 150,346 | $2.86M | 0.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 162,751 | $3.10M | 0.01% | −24,243−13.0% | Reduced |
| Principal Financial Group Inc | 169,149 | $3.22M | 0.00% | +1,399+0.8% | Added |
| Charles Schwab Investment Management Inc | 178,167 | $3.39M | 0.00% | +27,288+18.1% | Added |
| Integral Health Asset Management, LLC | 195,000 | $3.71M | 0.75% | +38,447+24.6% | Added |
| Bank of New York Mellon Corp | 214,291 | $4.08M | 0.00% | +33,780+18.7% | Added |
| AXA S.A. | 220,282 | $4.20M | 0.02% | +55,266+33.5% | Added |
| Barclays PLC | 221,843 | $4.23M | 0.00% | +192,220+648.9% | Added |
| American Century Companies Inc | 222,472 | $4.24M | 0.00% | +57,252+34.7% | Added |
| Northern Trust Corp | 241,813 | $4.61M | 0.00% | +8,528+3.7% | Added |
| Bridgeway Capital Management, LLC | 243,500 | $4.64M | 0.12% | +128,500+111.7% | Added |
| Acadian Asset Management LLC | 261,566 | $4.98M | 0.03% | −29,173−10.0% | Reduced |
| Citigroup Inc | 294,253 | $5.61M | 0.01% | +168,551+134.1% | Added |
| Ameriprise Financial Inc | 298,333 | $5.68M | 0.00% | +203,749+215.4% | Added |
| Goldman Sachs Group Inc | 343,601 | $6.55M | 0.00% | −67,470−16.4% | Reduced |
| Bank of America Corp | 346,020 | $6.59M | 0.00% | +195,774+130.3% | Added |
| AQR Capital Management LLC | 360,881 | $6.88M | 0.02% | −84,229−18.9% | Reduced |
| Renaissance Technologies LLC | 392,900 | $7.49M | 0.01% | +60,600+18.2% | Added |
| Artal Group S.A. | 400,000 | $7.62M | 0.40% | 00.0% | Unchanged |
| FMR LLC | 446,277 | $8.50M | 0.00% | +15,081+3.5% | Added |
| Geode Capital Management, LLC | 446,881 | $8.51M | 0.00% | +48,806+12.3% | Added |
| Jacobs Levy Equity Management, Inc | 466,325 | $8.88M | 0.07% | +466,325 | New |
| PFM Health Sciences, LP | 537,954 | $10.2M | 0.39% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 542,905 | $10.3M | 0.00% | −16,394−2.9% | Reduced |
| Invesco Ltd. | 545,179 | $10.4M | 0.00% | +38,549+7.6% | Added |
| Millennium Management LLC | 738,356 | $14.1M | 0.02% | +413,659+127.4% | Added |
| Candriam Luxembourg S.C.A. | 739,517 | $14.1M | 0.10% | −48,134−6.1% | Reduced |
| Morgan Stanley | 833,894 | $15.9M | 0.00% | −219,340−20.8% | Reduced |
| Tang Capital Management LLC | 937,500 | $17.9M | 2.19% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,321,883 | $25.2M | 0.03% | +608,171+85.2% | Added |
| MPM Oncology Impact Management LP | 1,745,943 | $33.3M | 7.88% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,751,100 | $33.4M | 0.00% | +121,514+7.5% | Added |
| BVF Inc | 1,810,835 | $34.5M | 1.42% | −118,366−6.1% | Reduced |
| State Street Corp | 2,107,868 | $40.2M | 0.00% | −370,464−14.9% | Reduced |
| Boxer Capital, LLC | 2,154,058 | $41.0M | 2.31% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,738,785 | $52.2M | 19.87% | 00.0% | Unchanged |
| BlackRock Inc. | 4,317,157 | $82.2M | 0.00% | +595,920+16.0% | Added |
| Ra Capital Management, L.P. | 4,417,259 | $84.1M | 1.80% | 00.0% | Unchanged |
| IFP Advisors, Inc | 22 | – | – | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −930−100.0% | Sold out |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −822,112−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −197,700−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −147,900−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −62,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −61,193−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −51,430−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −41,511−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −36,202−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −24,738−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −22,162−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −22,127−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −21,181−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −19,649−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −18,913−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −16,900−100.0% | Sold out |
| Quantedge Capital Pte Ltd | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −11,864−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,236−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,714−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,017−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −735−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |